Last Updated: October 3, 2025
Analyzing Management
Leadership at public companies plays a pivotal role for hedge funds and asset managers during both initial due diligence and continuous risk assessment. With ManagementTrack, investors gain a consistent framework that filters out distractions—highlighting distinct strengths and weaknesses, signaling potential risks and opportunities, and establishing a straightforward connection between CEO actions and investment outcomes.
CEO Ashworth’s strategic & compliance history may challenge critical execution.
Analysis of Amedisys CEO Richard Ashworth
While his experience managing financial pressure is an asset, a reactive strategic history and past compliance issues may challenge his ability to execute on critical contract negotiations and the Optum integration.
Management evaluated Richard Ashworth’s track record and skillset against the following key factors for AMED:
- Renegotiating MA contracts to improve payer mix and margins.
- Solving clinical labor shortages to enable volume growth.
- Mitigating proposed CMS rate cuts to protect core revenue.
- Executing the Optum integration to capture deal value.
Richard Ashworth’s Track Record & Key Open Questions to Research
ManagementTrack provides track record analysis, career playbooks, strengths, and weaknesses for every CEO. It allows investors to dig deeper to uncover hard to find data to answer the most pressing questions.
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ for more information.
Question #1
Given his success with high-stakes transactions at Tivity and Amedisys, does Ashworth derive his energy from strategic deal-making, or does he demonstrate an equal passion for the granular, day-to-day operational challenges of managing a specialized clinical workforce and driving margin improvement?
Question #2
When facing competitive pressure at Walgreens, did Ashworth prioritize defending existing market share through incremental adjustments, or did he advocate for bold, proactive strategies to reshape the company’s competitive position, even if it meant near-term risk?
Question #3
Reflecting on his turnaround at Tivity, was Ashworth’s success primarily driven by a talent for strategically dismantling a flawed structure he inherited, or did he also demonstrate the ability to build a durable engine for organic growth that could thrive beyond the initial crisis?
Why Do Investors Use ManagementTrack?
How does ManagementTrack evaluate Richard Ashworth at AMED?
ManagementTrack assesses Richard Ashworth through its proprietary career analysis and confidential interviews with former colleagues. This process identifies his track record, core strengths, and potential weaknesses, which are then measured against AMED’s most critical challenges: renegotiating Medicare Advantage contracts, resolving clinical labor shortages, mitigating proposed CMS rate cuts, and executing the Optum integration.
Beyond individual profiles, what other methods does ManagementTrack use to link executive behavior to company performance?
ManagementTrack employs a suite of advanced analytical tools. Its proprietary linguistic models analyze earnings call transcripts to detect and contextualize executive evasion. The platform also systematically scrutinizes all insider transactions to isolate outlier trades that signal future over or underperformance. These data points contribute to the ManagementTrack Rating, a predictive 1-10 score for every executive, which gives investors a decisive view on how leadership will likely influence future results.
What is the scope of ManagementTrack’s coverage?
ManagementTrack offers continuous, real-time coverage of the complete C-suite for every publicly traded company.
How to Learn More
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ to see our deep dive analysis on any executive.
Author
Author: Colby Howard is the co-founder and President of Paragon Intel. Paragon Intel’s ManagementTrack is the premier executive analysis platform for hedge funds, asset managers, corporations, boards, and recruiters. Our proprietary data, built over a decade of analysis, allows us to analyze each public company executive to understand their fit and ability to execute at their company. We leverage our proprietary data – key quantitative research on an executive’s career plus interviews with their former colleagues – with public documents, including SEC filings (10-K, 10-Q), investor presentations, press releases, and earnings call transcripts. to build a holistic, evidence-based view of an executive’s capabilities and playbook.
Sources
Verified Career History by ManagementTrack for Richard Ashworth
Analysis of Capital Allocation, Performance, and Fundamentals across career by ManagementTrack
Amedisys, Inc. 10Q
Amedisys, Inc. 10K
Amedisys, Inc. Earnings Calls
Amedisys, Inc. Press Releases
Relevant Links
- For more information on ManagementTrack’s Data visit: https://paragonintel.com/management-track-data/
- For more information on ManagementTrack’s Interview & Analysis visit: https://paragonintel.com/management-track-reports/
- For more information on ManagementTrack’s Interview library visit: https://paragonintel.com/management-track-report-library/
- For more information on ManagementTrack’s Evasion Analysis visit: https://paragonintel.com/earnings-call-evasion/
- For more information on how ManagementTrack helps hedge funds and asset managers visit: https://paragonintel.com/
